NewAmsterdam Pharma Company N.V. Ordinary Shares share price logo

NewAmsterdam Pharma Company N.V. Ordinary Shares

NASDAQ: NAMS

Mid Cap

$38.89

-0.70

(-1.77%)

as on

NewAmsterdam Pharma Company N.V. Ordinary Shares Stock Performance

as on May 13, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $38.28
    $39.74
    downward going graph

    1.57%

    Downside

    2.19%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $16.79
    $42.21
    downward going graph

    56.84%

    Downside

    8.52%

    Upside

    downward going graph

NewAmsterdam Pharma Company N.V. Ordinary Shares share price movements today

Previous Close
$39.59
Open
$39.52
Volume
2.2M
Day's Low - High
$38.28 - $39.74
52 Week Low - High
$16.79 - $42.21

NewAmsterdam Pharma Company N.V. Ordinary Shares Historical Returns

1 Month Return
+ 13.9 %
3 Month Return
+ 13.57 %
1 Year Return
+ 105.98 %
3 Year Return
+ 204.54 %
5 Year Return
0 %

NewAmsterdam Pharma Company N.V. Ordinary Shares Stock Fundamentals & Key Indicators

Check NewAmsterdam Pharma Company N.V. Ordinary Shares market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$4.6B

EPS (TTM)

-1.5912

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-225.5M

Revenue (TTM)

22.5M

Profit Margin

0.00%

Return On Equity TTM

-28.29%

NewAmsterdam Pharma Company N.V. Ordinary Shares vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of NewAmsterdam Pharma Company N.V. Ordinary Shares with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
NewAmsterdam Pharma Company N.V. Ordinary Shares image
NewAmsterdam Pharma Company N.V. Ordinary Shares
BUY$4.6BNANA0.00%
Alnylam Pharmaceuticals Inc image
Alnylam Pharmaceuticals Inc
BUY$39.4B113.59%74.1312.55%
BeiGene, Ltd. image
BeiGene, Ltd.
NA$32.2BNA70.468.94%
Vertex Pharmaceuticals Inc image
Vertex Pharmaceuticals Inc
BUY$109.1B104.61%25.5135.51%
Regeneron Pharmaceuticals Inc image
Regeneron Pharmaceuticals Inc
BUY$74.9B40.55%17.4529.65%

Stock Returns calculator for NewAmsterdam Pharma Company N.V. Ordinary Shares Stock including INR - Dollar returns

The NewAmsterdam Pharma Company N.V. Ordinary Shares stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

NewAmsterdam Pharma Company N.V. Ordinary Shares investment value today

Current value as on today

₹2,27,927

Returns

₹1,27,927

(+127.93%)

Returns from NewAmsterdam Pharma Company N.V. Ordinary Shares Stock

₹1,02,341 (+102.34%)

Dollar Impact

₹25,586 (+25.59%)

Analyst Recommendation on NewAmsterdam Pharma Company N.V. Ordinary Shares Stock

Based on 14 analysts

BUY

92.86%

Buy

7.14%

Hold

0.00%

Sell

Based on 14 analysts, 92.86% of analysts recommend a 'BUY' rating for NewAmsterdam Pharma Company N.V. Ordinary Shares. Average target price of $49.57

NewAmsterdam Pharma Company N.V. Ordinary Shares Share Price Target

Get share price movements and forecasts by analysts on NewAmsterdam Pharma Company N.V. Ordinary Shares.

What analysts predicted

21.55%UPSIDE

Target Price

$49.57

Current Price

$38.89

Analyzed by

14 Analysts

Target

$49.57

NewAmsterdam Pharma Company N.V. Ordinary Shares target price $49.57, a slight upside of 21.55% compared to current price of $38.89. According to 14 analysts rating.

Indian Investors' Interest in NewAmsterdam Pharma Company N.V. Ordinary Shares Stock

Search interest for NewAmsterdam Pharma Company N.V. Ordinary Shares Stock has increased by 130% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:130% versus previous 30 day period

NewAmsterdam Pharma Company N.V. Ordinary Shares Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
0
1
2
32
12
2
19
0
0
3
Gross Profit
0
1
2
32
12
2
19
0
0
2
Operating Income
-51
-55
-52
-25
-43
-68
-35
-55
-65
-58
EBITDA
-50
-55
-51
-23
-111
-68
-35
-71
-65
-58
Interest Expense
1
0
0
1
3
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
-
Income Before Tax
-49
-93
-39
-16
-92
-39
-17
-72
-74
-48
Income Tax Expense
0
-3
-12
0
-
-
-
-
-
-
Net Income
-53
-101
-41
-18
-92
-39
-17
-72
-74
-48
Net Profit Margin
-6163.76%
-6692.86%
-1711.58%
-57.18%
-721.71%
-1327.30%
-90.70%
-20691.09%
-234134.38%
-1593.45%

NewAmsterdam Pharma Company N.V. Ordinary Shares Annual Profit & Loss

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
108
15
45
22
Gross Profit
-
0
108
15
45
22
Operating Income
-6
-34
-3
-182
-176
-225
EBITDA
-6
-41
-22
-176
-241
-242
Interest Expense
0
0
0
6
-
-
Depreciation
0
0
0
0
0
0
Income Before Tax
-7
-41
-22
-176
-241
-203
Income Tax Expense
0
0
70
0
0
-
Net Income
-8
-47
-23
-193
-241
-203
Net Profit Margin
0.00%
0.00%
-22.04%
-1255.76%
-530.25%
-905.74%

NewAmsterdam Pharma Company N.V. Ordinary Shares Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-93
-39
-16
-92
-39
-17
39
-74
-48
Operating Cash Flow
-54
-53
-12
-37
-36
-37
-32
-40
-30
Investing Cash Flow
0
0
0
-62
2
-159
2
-21
-11
Financing Cash Flow
198
4
0
456
6
3
5
13
11
Change in Cash
140
-50
-7
349
-23
-184
-24
-48
-32

NewAmsterdam Pharma Company N.V. Ordinary Shares Annual Cash Flow

All numbers in Millions USD

Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-41
-22
-176
-241
-203
Operating Cash Flow
-29
10
-141
-158
-147
Investing Cash Flow
0
0
0
-62
-174
Financing Cash Flow
84
391
8
659
29
Change in Cash
50
407
-127
431
-280

Global Institutional Holdings in NewAmsterdam Pharma Company N.V. Ordinary Shares

Funds
Holdings
HHG PLC
2%
Maverick Capital Ltd
1.62%
Capital World Investors
8.54%
RA Capital Management, LLC
8.17%
Duquesne Family Office LLC
2.63%
See all

Insights on NewAmsterdam Pharma Company N.V. Ordinary Shares

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, NAMS has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 32.0K → 3.04M (in $), with an average increase of 99.0% per quarter

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, NAMS has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -74.92M → -48.44M (in $), with an average increase of 54.7% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, NAMS stock has moved up by 27.8%

About NewAmsterdam Pharma Company N.V. Ordinary Shares

NewAmsterdam Pharma Company N.V., a late-stage biopharmaceutical company, develops therapies to enhance patient care in populations with cardiometabolic disease. It is developing Obicetrapib, an oral low-dose cholesteryl ester transfer protein (CETP) inhibitor, that is in various clinical trials as a monotherapy and a combination therapy with ezetimibe for lowering LDL-C for cardiovascular diseases. The company also develops Obicetrapib which is in Phase 2a clinical trial for Alzheimer's disease. NewAmsterdam Pharma Company N.V. is headquartered in Naarden, the Netherlands.
OrganisationNewAmsterdam Pharma Company N.V. Ordinary Shares
HeadquartersGooimeer 2-35, Naarden, Netherlands, 1411 DC
IndustryBiotechnology
CEODr. Michael Harvey Davidson FACC, Facp., M.D.
E-voting on sharesClick here to vote

Key Management of NewAmsterdam Pharma Company N.V. Ordinary Shares

Name

Title

Mr. Mayur Amrat Somaiya

Chief Financial Officer

Ms. Louise Kooij

Chief Accounting Officer

Mr. Matthew Philippe

Executive VP &Head of Investor Relations

Dr. Michael Harvey Davidson FACC, Facp., M.D.

CEO, President & Executive Director

Dr. Johannes Jacob Pieter Kastelein FESC, M.D., Ph.D.

Founder, Chief Scientific Officer, Member of Executive Board & Director

Ms. Maryellen McQuade

Chief People Officer

Ms. Juliette Audet M.B.A., M.Sc.

Chief Strategy & Business Officer

Dr. Marc Ditmarsch M.D.

Chief Development Officer

Mr. Douglas F. Kling

Chief Operating Officer

Mr. Bob Rambo

Executive Vice President of Marketing

FAQs

What is NewAmsterdam Pharma Company N.V. Ordinary Shares share price today?

NewAmsterdam Pharma Company N.V. Ordinary Shares share price today is $38.89 as on at the close of the market. NewAmsterdam Pharma Company N.V. Ordinary Shares share today touched a day high of $39.74 and a low of $38.28.

What is the 52 week high and 52 week low for NewAmsterdam Pharma Company N.V. Ordinary Shares share?

NewAmsterdam Pharma Company N.V. Ordinary Shares share touched a 52 week high of $42.21 on and a 52 week low of $16.79 on . NewAmsterdam Pharma Company N.V. Ordinary Shares stock price today i.e. is closed at $38.89,which is 7.85% down from its 52 week high and 131.69% up from its 52 week low.

What is NewAmsterdam Pharma Company N.V. Ordinary Shares's market capitalisation today?

NewAmsterdam Pharma Company N.V. Ordinary Shares market capitalisation is $0.00T as on .

How to invest in NewAmsterdam Pharma Company N.V. Ordinary Shares Stock (NAMS) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for NewAmsterdam Pharma Company N.V. Ordinary Shares on INDmoney app. Click on Buy button. You can invest as low as $1.5 in NewAmsterdam Pharma Company N.V. Ordinary Shares Shares that will get you 0.0386 shares as per NewAmsterdam Pharma Company N.V. Ordinary Shares share price of $38.89 per share as on May 13, 2026 at 1:29 am IST.

What is the minimum amount required to buy NewAmsterdam Pharma Company N.V. Ordinary Shares Stock (NAMS) from India?

Indian investors can start investing in NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS) shares with as little as ₹95.618 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹956.18 in NewAmsterdam Pharma Company N.V. Ordinary Shares stock (as per the Rupee-Dollar exchange rate as on ). Based on NewAmsterdam Pharma Company N.V. Ordinary Shares share’s latest price of $38.89 as on May 13, 2026 at 1:29 am IST, you will get 0.2571 shares of NewAmsterdam Pharma Company N.V. Ordinary Shares. Learn more about fractional shares .